Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension

Lancet

Volumn 350, Issue 9080, 1997, Pages 757-764

  Staessen, Jan A ^m   Fagard, Robert ^m   Thijs, Lutgarde ^m   Celis, Hilde ^m   Arabidze, Guramy G ^a   Birkenhäger, Willem H ^b   Bulpitt, Christopher J ^c   De Leeuw, Peter W ^d   Dollery, Colin T ^m   Fletcher, Astrid E ^e   Forette, Françoise ^f   Leonetti, Gastone ^g   Nachev, Choudomir ^h   O' Brien, Eoin T ⁱ   Rosenfeld, Joseph ^k   Rodicio, José L ^j   Tuomilehto, Jaakko ^l   Zanchetti, Alberto ^g  

^a INSTITUTE OF EXPERIMENTAL CARDIOLOGY   (Russian Federation)

^b ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

^d MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^e LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^f Paris Descartes University   (France)

^g UNIVERSITY OF MILAN   (Italy)

^h UNIVERSITY HOSPITAL ALEXANDROVSKA   (Bulgaria)

ⁱ BEAUMONT HOSPITAL   (Ireland)

^j HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^k TEL AVIV UNIVERSITY   (Israel)

^l NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^m NONE

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ENALAPRIL; HYDROCHLOROTHIAZIDE; NITRENDIPINE;

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DOUBLE BLIND PROCEDURE; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STROKE; SUDDEN DEATH; SYSTOLIC BLOOD PRESSURE; SYSTOLIC HYPERTENSION;

EID: 0343487983     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(97)05381-6     Document Type: Article

References (34)

1. Staessen J, Amery A, Fagard R. Isolated systolic hypertension in the elderly. J Hypertens 1990; 8: 393-405.
2. Amery A, Birkenhäger W, Bulpitt CJ, et al. Syst-Eur: a multicentre trial on the treatment of isolated systolic hypertension in the elderly: objectives, protocol, and organization. Aging Clin Exp Res 1991; 3: 287-302.
3. Goa KL, Sorkin EM. Nitrendipine. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in the treatment of hypertension. Drugs 1987; 33: 123-55.
4. SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension: final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA 1991; 265: 3255-64.
5. Fletcher A, Spiegelhalter D, Staessen J, Thijs L, Bulpitt C. Implications for trials in progress of publication of positive results. Lancet 1993; 342: 653-57.
6. Kaplan NM. Systolic Hypertension in the Elderly Program (SHEP) and Swedish Trial in Old Patients with Hypertension (STOP): the promises and the potential problems. Am J Hypertens 1992; 5: 331-34.
7. Ménard J, Day M, Chatellier G, Laragh JH. Some lessons from Systolic Hypertension in the Elderly Program (SHEP). Am J Hypertens 1992; 5: 325-30.
8. Staessen J, Fagard R, Amery A. Isolated systolic hypertension in the elderly: implications of SHEP for clinical practice and for the ongoing trials. J Hum Hypertens 1991; 5: 469-74.
9. Staessen JA, Amery A, Birkenhäger W. Inverse association between baseline pressure and benefit from treatment in isolated systolic hypertension. Hypertension 1994; 23: 269-70.
10. Pahor M, Guralnik JM, Furberg CD, Carbonin P, Havlik RJ. Risk of gastrointestinal haemorrhage with calcium antagonists in hypertensive persons over 67 years old. Lancet 1996; 347: 1061-65.
11. Pahor M, Guralnik JM, Ferrucci L, et al. Calcium-channel blockade and incidence of cancer in aged populations. Lancet 1996; 348: 493-97.
12. Furberg CD, Patsy BM, Meyer JV. Nifedipine: dose-related increase in mortality in patients with coronary heart disease. Circulation 1995; 92: 1326-31.
13. Psaty BM, Heckbert SR, Koepsell TD, et al. The risk of myocardial infarction associated with antihypertensive drug therapies. JAMA 1995; 274: 620-25.
14. 41st World Medical Assembly. Declaration of Helsinki: recommendations guiding physicians in biomedical research involving human subjects. Bull Pan Am Health Organ 1990; 24: 606-09.
15. International Classification of Diseases. Manual of the international statistical classification of diseases, injuries, and causes of death: based on the recommendations of the ninth revision conference, 1975, and adopted by the twenty-ninth World Health Assembly, vol 1. Geneva, Switzerland: World Health Organization, 1977.
16. O'Brien PC, Fleming TR. A multiple testing procedure for clinical trials. Biometrics 1979; 35: 549-56.
17. Amery A, Birkenhäger W, Brixko P, et al. Mortality and morbidity results from the European Working Party on High Blood Pressure in the Elderly trial. Lancet 1985; i: 1349-54.
18. Coope J, Warrender TS. Randomised trial of treatment of hypertension in elderly patients in primary care. BMJ 1986; 293: 1145-51.
19. Dahlöf B, Lindholm LH, Hansson L, Scherstén B, Ekbom T, Wester P-O. Morbidity and mortality in the Swedish Trial in Old Patients with Hypertension (STOP-Hypertension). Lancet 1991; 338: 1281-85.
20. Kuramato K, Mutsushita S, Kuwajima I. The pathogenetic role and treatment of elderly hypertension. Jpn Circ J 1981; 45: 833-43.
21. MRC Working Party. Medical Research Council trial of treatment of hypertension in older adults: principal results. BMJ 1992; 304: 405-12.
22. Management Committee. Treatment of mild hypertension in the elderly: a study initiated and administered by the National Heart Foundation of Australia. Med J Aust 1981; 2: 398-402.
23. Thijs L, Fagard R, Lijnen P, Staessen J, Van Hoof R, Amery A. A meta-analysis of outcome trials in elderly hypertensives. J Hypertens 1992; 10: 1103-09.
24. Lever AF, Ramsay LE. Editorial review: treatment of hypertension in the elderly. J Hypertens 1995; 13: 571-79.
25. Medical Research Council Working Party. MRC trial of treatment of mild hypertension: principal results. BMJ 1985; 291: 97-104.
26. Celis H, Yodfat Y, Thijs L, et al. Antihypertensive therapy in older patients with isolated systolic hypertension: the Syst-Eur experience in general practice. Fam Pract 1996; 13: 138-43.
27. Furberg CD, Psaty BM. Calcium antagonists: not appropriate as first line antihypertensive agents. Am J Hypertens 1996: 9: 122-25.
28. Swales JD. Pharmacological treatment of hypertension. Lancet 1994; 344: 380-85.
29. The Joint National Committee on Detection Evaluation and Treatment of High Blood Pressure. The fifth report of the Joint National Committee on Detection, Evaluation and Treatment of High Blood Pressure (JNC V). Arch Intern Med 1993; 153: 154-83.
30. The Guidelines Subcommittee of the WHO/ISH Mild Hypertension Liaison Committee. 1993 guidelines for the management of mild hypertension: memorandum from a World Health Organization/International Society of Hypertension meeting. Hypertension 1993; 22: 392-403.
31. Zanchetti A. Guidelines for the management of hypertension: the World Health Organization/International Society of Hypertension view. J Hypertens 1995; 13 (suppl 2): S119-22.
32. Gong L, Zhang W, Zhu Y, et al. Shanghai trial of nifedipine in the elderly (STONE). J Hypertens 1996; 14: 1237-45.
33. Hamet P, Gong L. Chinese contribution to trials on antihypertensive therapy. J Hypertens 1996; 14 (suppl 2): S123-28.
34. Wang J, Liu G, Wang X, et al. Long-term blood pressure control in older Chinese patients with isolated systolic hypertension: a progress report on the Syst-China trial. J Hum Hypertens 1966; 10: 735-42.